Stock listing

NASDAQ:MURA Mural Oncology PLC Stock

Follow Mural Oncology PLC into a list and get an email when it puts out news.

Last close · NASDAQ:MURA

$2.04 USD

Close on Dec 4, 2025 · No longer trades

Nov 16, 2023 to last close -46.3% · weekly closes, Nov 16, 2023 – Dec 4, 2025
Lowest – highest close
$0.995 – $6.01 USDSince Nov 16, 2023 · lowest Apr 10, 2025 · highest Dec 28, 2023

Delisted NASDAQ:MURA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:MURA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Mural Oncology PLC on 6ix

Decks
4 decks · latest Mar 11, 2025

Decks

DeckKindSlidesDate
Investor Presentation (March 2025)Investor deck35 slidesMar 11, 2025
Investor Presentation (January 2025)Investor deck35 slidesJan 10, 2025
Investor Day (September 2024)Investor day59 slidesSep 26, 2024
Investor Presentation (January 2024)Investor deck29 slidesJan 8, 2024

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
George Golumbeski
Other companies: Acumen Pharmaceuticals, Inc. (Chairman of its Board of Directors · Since at least Nov 6, 2025); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Sage Therapeutics Inc (Director · Since at least Jan 22, 2019); Corbus Pharmaceuticals Holdings, Inc. (Director · Jul 6, 2020 – Jul 6, 2020 · Past); Enanta Pharmaceuticals, Inc. (Director · Feb 7, 2014 – Feb 26, 2020 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past)
Director · Since at least Jul 30, 2024
Scott Thomas Jackson
Other companies: Spero Therapeutics, Inc. (Director · Since at least Apr 16, 2020); MacroGenics, Inc. (Director · Since at least Jan 24, 2017); Crescent Biopharma, Inc. (Director · Nov 27, 2018 – May 1, 2024 · Past); Celator Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 14, 2013 – Jul 12, 2016 · Past)
Director · Since at least Oct 31, 2023
Benjamin Hickey
Other companies: Bristol-Myers Squibb Company (President, RayzeBio Org. · Since at least Feb 26, 2024); Surface Oncology Inc (Director · Dec 9, 2021 – Jun 8, 2022 · Past); Halozyme Therapeutics, Inc. (SVP, Chief Commerical Officer · Sep 10, 2018 – Oct 1, 2019 · Past)
Director · Since at least Oct 31, 2023
Susan Altschuller
Other companies: Climb Bio, Inc. (Chief Financial Officer · Since at least Oct 1, 2025); Cerevel Therapeutics Holdings Inc (Chief Financial Officer · May 15, 2023 – Aug 1, 2024 · Past); ImmunoGen Inc (SVP AND CFO · Jul 20, 2020 – May 20, 2022 · Past)
Director · Oct 31, 2023 – Aug 14, 2024 · Past
Adam D Cutler
Other companies: InMed Pharmaceuticals Inc. (Director · Nov 12, 2020 – Jan 24, 2022 · Past); Molecular Templates Inc (See remarks · Nov 13, 2017 – Feb 15, 2021 · Past)
Chief Financial Officer · Since at least Nov 15, 2023
Francis M Cuss
Other companies: Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Bristol-Myers Squibb Company (EVP & CSO · May 4, 2010 – Mar 10, 2017 · Past)
Director · Since at least Oct 31, 2023
Maiken Keson-Brookes
Other companies: Rubius Therapeutics Inc (CLO & Corp. Secretary · Nov 18, 2019 – Jan 29, 2022 · Past); uniQure N.V. (General Counsel · Jan 1, 2017 – Jan 27, 2017 · Past)
Chief Legal Officer · Since at least Nov 15, 2023
Sachiyo Minegishi
Other companies: Akouos Inc (Chief Financial Officer · Oct 1, 2020 – Dec 1, 2022 · Past)
Director · Since at least Sep 20, 2024
Vicki L Goodman
Other companies: Exelixis, Inc. (EVP, Prod Dev & Med Aff &CMO · Jan 4, 2022 – Apr 3, 2023 · Past)
Chief Medical Officer · Since at least Nov 15, 2023
Caroline LoewChief Executive Officer, Director · Since at least Oct 31, 2023

Open People

Log in to ask 6ix AI your own questions about Mural Oncology PLC.